41. Botulinum toxin treatment abobotulinumtoxina (Dysport)/incobotulinumtoxina (Xeomin) dose ratio. (25th December 2016) Authors: Fletcher, Nicholas A.; Crummie, Nicola Journal: Toxicon Issue: Volume 123(2016) Supplement Page Start: S29 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
42. Botulinum toxin treatment for spasticity: Clinical experience with changing from abobotulinumtoxina (DYSPORT) to incobotulinumtoxina (XEOMIN). (25th December 2016) Authors: Cossar, Martin; Cozens, Alastair Journal: Toxicon Issue: Volume 123(2016) Supplement Page Start: S19 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
43. Botulinum toxin type A injection for primary headache syndrome postintracerebral hemorrhage: A case report. (25th December 2016) Authors: Motta-Valencia, Keryl; Burgos-Mártir, Melissa Journal: Toxicon Issue: Volume 123(2016) Supplement Page Start: S65 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
44. Botulinum toxin use improves quality of life and care in patients with spasticity from advanced dementia. (25th December 2016) Authors: Ethans, Karen; Casey, Alan; Hamm, Rachel; Miller, Nicolas Journal: Toxicon Issue: Volume 123(2016) Supplement Page Start: S27 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
45. Botulinum toxins for chronic migraine: Clinical trials and technical aspects. (25th December 2016) Authors: Tassorelli, Cristina; Sances, G.; Sandrini, G. Journal: Toxicon Issue: Volume 123(2016) Supplement Page Start: S79 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
46. Central effects of BoNT-A following intramuscular injections in humans. (25th December 2016) Authors: Aymard, Claire; Marchand-Pauvert, Véronique Journal: Toxicon Issue: Volume 123(2016) Supplement Page Start: S4 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
47. Central effects of botulinum neurotoxin. (25th December 2016) Authors: Caleo, Matteo; Restani, Laura Journal: Toxicon Issue: Volume 123(2016) Supplement Page Start: S10 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
48. Clinical and pharmaceutical applications of the Endopep-MS assay. (25th December 2016) Authors: Rosen, Osnat; Feldberg, Liron; Gura, Sigalit; Ozeri, Eyal; Barnea, Ada; Turgeman, Amram; Diamant, Eran; Ben David, Alon; Schwartz, Arieh; Zichel, Ran Journal: Toxicon Issue: Volume 123(2016) Supplement Page Start: S71 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
49. Clinical applications of neurotoxin injections in Parkinson's disease and parkinson-plus syndromes: Experience of a neurology department. (25th December 2016) Authors: Velon, Ana Graça; Mendes, Michel; Almendra, Ricardo; Barbosa, Vera; Raimundo, Ana Rita; Almeida, Ana; Rego, Inês; Veiga, Andreia Journal: Toxicon Issue: Volume 123(2016) Supplement Page Start: S83 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
50. Clinical characteristics of oromandibular dystonia: A multicenter review of 201 caseS. (25th December 2016) Authors: Scorr, Laura M.; Factor, Stewart A.; Jinnah, H.A. Journal: Toxicon Issue: Volume 123(2016) Supplement Page Start: S75 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗